HRAS and head and neck squamous cell carcinoma: The outcome of the study was in line with earlier findings that showed TP53, CDKN2A, FAT1, CASP8, NOTCH1, and HRAS as the main mutations that drove cancer progression in HPV-negative HNSCC.